Welcome to the CJU website » LOG IN


Genetically-informed treatment for advanced and metastatic prostate cancer
Department of Hematology and Oncology, Northwestern University, Chicago, Illinois, USA
Oct 2019 (Vol. 26, Issue 52, Pages( 54 - 56)
PMID: 31629435


Text-Size + 

  • The landscape of genetic testing for prostate cancer is rapidly evolving. There is increasing evidence that individuals with germline mutations in DNA-repair genes are more responsive to targeted therapies. Due to potential implications for treatment, these genes should be taken into consideration when determining the scope of genetic testing.

Current Issue

June 2021, Vol.28 No.3
canadian journal of urology